- Home
- RLMD vs APDN Comparison
RLMD vs APDN Comparison
Compare RLMD & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- APDN
- Stock Information
- Founded
- RLMD 2004
- APDN 1983
- Country
- RLMD United States
- APDN United States
- Employees
- RLMD N/A
- APDN N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- RLMD Health Care
- APDN Consumer Discretionary
- Exchange
- RLMD Nasdaq
- APDN Nasdaq
- Market Cap
- RLMD 11.5M
- APDN 9.4M
- IPO Year
- RLMD N/A
- APDN N/A
- Fundamental
- Price
- RLMD $0.27
- APDN $0.06
- Analyst Decision
- RLMD Hold
- APDN Strong Buy
- Analyst Count
- RLMD 4
- APDN 1
- Target Price
- RLMD $4.25
- APDN $1.50
- AVG Volume (30 Days)
- RLMD 517.6K
- APDN 3.4M
- Earning Date
- RLMD 05-07-2025
- APDN 02-13-2025
- Dividend Yield
- RLMD N/A
- APDN N/A
- EPS Growth
- RLMD N/A
- APDN N/A
- EPS
- RLMD N/A
- APDN N/A
- Revenue
- RLMD N/A
- APDN $3,736,873.00
- Revenue This Year
- RLMD N/A
- APDN $29.07
- Revenue Next Year
- RLMD N/A
- APDN $70.38
- P/E Ratio
- RLMD N/A
- APDN N/A
- Revenue Growth
- RLMD N/A
- APDN N/A
- 52 Week Low
- RLMD $0.24
- APDN $0.06
- 52 Week High
- RLMD $5.84
- APDN $11.00
- Technical
- Relative Strength Index (RSI)
- RLMD 35.11
- APDN 20.10
- Support Level
- RLMD $0.25
- APDN $0.06
- Resistance Level
- RLMD $0.29
- APDN $0.15
- Average True Range (ATR)
- RLMD 0.02
- APDN 0.01
- MACD
- RLMD 0.01
- APDN -0.01
- Stochastic Oscillator
- RLMD 32.11
- APDN 6.45
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.